Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Steven M McPhail. (2016) Multimorbidity in chronic disease: impact on health care resources and costs. Risk Management and Healthcare Policy 9, pages 143-156.
Read now
Read now
Jan Klimas, Anna Keane, Walter Cullen, Fergus O'Kelly & Gerard Bury. (2016) Seventeen year mortality in a cohort of patients attending opioid agonist treatment in Ireland. Commentary on ‘methadone-maintained patients in primary care have higher rates of chronic disease’ (O’Toole et al., European Journal of General Practice 2014;20:275–80). European Journal of General Practice 22:1, pages 64-65.
Read now
Read now
Articles from other publishers (22)
Katja Troberg, Karin Lundqvist, Helena Hansson, Anders Håkansson & Disa Dahlman. (2022) Healthcare seeking among Swedish patients in opioid substitution treatment – a mixed methods study on barriers and facilitators. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Teodor Vikbladh, Katja Troberg, Anders Håkansson & Disa Dahlman. (2022) Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare. BMC Health Services Research 22:1.
Crossref
Crossref
Anne Berit Bech, Thomas Clausen, Helge Waal, Gerd Jorunn Møller Delaveris & Ivar Skeie. (2021) Organ pathologies detected post‐mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation‐wide 2‐year cross‐sectional study. Addiction 117:4, pages 977-985.
Crossref
Crossref
Erin Kelty, Agata Chrzanowska & David B. Preen. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1851
1867
.
Erin Kelty, Agata Chrzanowska & David B. Preen. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
17
.
Chieh-Liang Huang, I-Ju Tsai, Wen-Chi Lin, Ing-Kang Ho, Ruey-Yun Wang & Cynthia Wei-Sheng Lee. (2021) Augmentation in Healthcare Utilization of Patients with Opioid Use Disorder After Methadone Maintenance Treatment: A Retrospective Nationwide Study. Advances in Therapy 38:6, pages 2908-2919.
Crossref
Crossref
Giliane Joseph, Kristine Torres-Lockhart, Melissa R. Stein, Pamela A. Mund & Shadi Nahvi. (2021) Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19. Journal of Substance Abuse Treatment 122, pages 108219.
Crossref
Crossref
Katja Troberg, Pernilla Isendahl, Marianne Alanko Blomé, Disa Dahlman & Anders Håkansson. (2020) Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden. BMC Psychiatry 20:1.
Crossref
Crossref
Disa Dahlman, Malin Ekefäll & Lars Garpenhag. (2020) Health Literacy among Swedish Patients in Opioid Substitution Treatment: A Mixed-Methods Study. Drug and Alcohol Dependence 214, pages 108186.
Crossref
Crossref
Joe Hulin, Arjuna Brodie, John Stevens & Caroline Mitchell. (2020) Prevalence of respiratory conditions among people who use illicit opioids: a systematic review. Addiction 115:5, pages 832-849.
Crossref
Crossref
Cynthia Vlad, Julia H. Arnsten & Shadi Nahvi. (2020) Achieving Smoking Cessation Among Persons with Opioid Use Disorder. CNS Drugs 34:4, pages 367-387.
Crossref
Crossref
Ide Delargy, Des Crowley & Marie Claire Van Hout. (2019) Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice. Harm Reduction Journal 16:1.
Crossref
Crossref
Anne Berit Bech, Thomas Clausen, Helge Waal, Jūratė Šaltytė Benth & Ivar Skeie. (2019) Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study. BMC Health Services Research 19:1.
Crossref
Crossref
Nicola R. Jones, Marian Shanahan, Timothy Dobbins, Louisa Degenhardt, Mark Montebello, Natasa Gisev & Sarah Larney. (2019) Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia. Drug and Alcohol Review 38:6, pages 690-698.
Crossref
Crossref
Yea-Jen HsuJill A. MarstellerSarah G. KachurMichael I. Fingerhood. (2019) Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost. Population Health Management 22:4, pages 292-299.
Crossref
Crossref
C. Higgins, B.H. Smith & K. Matthews. (2019) Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. British Journal of Anaesthesia 122:6, pages e114-e126.
Crossref
Crossref
Katja Troberg, Anders Håkansson & Disa Dahlman. (2019) Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment. Journal of Addiction 2019, pages 1-10.
Crossref
Crossref
Cassie Higgins, Blair H. Smith & Keith Matthews. (2018) Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence. Drug and Alcohol Dependence 193, pages 131-136.
Crossref
Crossref
Matthew Hickman, Colin Steer, Kate Tilling, Aaron G. Lim, John Marsden, Tim Millar, John Strang, Maggie Telfer, Peter Vickerman & John Macleod. (2018) The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction 113:8, pages 1461-1476.
Crossref
Crossref
Andrew Radley, Karen Melville, Phyllis Easton, Brian Williams & John F Dillon. (2017) ‘Standing Outside the Junkie Door’—service users’ experiences of using community pharmacies to access treatment for opioid dependency. Journal of Public Health 39:4, pages 846-855.
Crossref
Crossref
Christine Gadbois, Elizabeth D. Chin & Lee Dalphonse. (2016) Health Promotion in an Opioid Treatment Program. Journal of Addictions Nursing 27:2, pages 127-142.
Crossref
Crossref
Suzanne Sayuri Ii, Lisa Ryan & Joanne Neale. (2016) Diet and nutrient intake of people receiving opioid agonist treatment (OAT): implications for recovery. Drugs and Alcohol Today 16:1, pages 59-71.
Crossref
Crossref